Literature DB >> 28356926

Familial risk for lung cancer.

Madiha Kanwal1, Xiao-Ji Ding2, Yi Cao2.   

Abstract

Lung cancer, which has a low survival rate, is a leading cause of cancer-associated mortality worldwide. Smoking and air pollution are the major causes of lung cancer; however, numerous studies have demonstrated that genetic factors also contribute to the development of lung cancer. A family history of lung cancer increases the risk for the disease in both smokers and never-smokers. This review focuses on familial lung cancer, in particular on the familial aggregation of lung cancer. The development of familial lung cancer involves shared environmental and genetic factors among family members. Familial lung cancer represents a good model for investigating the association between environmental and genetic factors, as well as for identifying susceptibility genes for lung cancer. In addition, studies on familial lung cancer may help to elucidate the etiology and mechanism of lung cancer, and may identify novel biomarkers for early detection and diagnosis, targeted therapy and improved prevention strategies. This review presents the aetiology and molecular biology of lung cancer and then systematically introduces and discusses several aspects of familial lung cancer, including the characteristics of familial lung cancer, population-based studies on familial lung cancer and the genetics of familial lung cancer.

Entities:  

Keywords:  environmental factor; familial cancer; genetic factor; germline mutation; lung cancer; oncogene; tumour suppressor gene

Year:  2016        PMID: 28356926      PMCID: PMC5351216          DOI: 10.3892/ol.2016.5518

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  93 in total

1.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

Review 2.  Guilty as charged: B-RAF is a human oncogene.

Authors:  Mathew J Garnett; Richard Marais
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

3.  Prevalence and causes of air pollution and lung cancer in Xuanwei City and Fuyuan County, Yunnan Province, China.

Authors:  Yi Cao; Huaping Gao
Journal:  Front Med       Date:  2012-05-09       Impact factor: 4.592

4.  Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval.

Authors:  J R Testa; J M Siegfried; Z Liu; J D Hunt; M M Feder; S Litwin; J Y Zhou; T Taguchi; S M Keller
Journal:  Genes Chromosomes Cancer       Date:  1994-11       Impact factor: 5.006

5.  ROS1 rearrangements define a unique molecular class of lung cancers.

Authors:  Kristin Bergethon; Alice T Shaw; Sai-Hong Ignatius Ou; Ryohei Katayama; Christine M Lovly; Nerina T McDonald; Pierre P Massion; Christina Siwak-Tapp; Adriana Gonzalez; Rong Fang; Eugene J Mark; Julie M Batten; Haiquan Chen; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; David P Carbone; Hongbin Ji; Jeffrey A Engelman; Mari Mino-Kenudson; William Pao; A John Iafrate
Journal:  J Clin Oncol       Date:  2012-01-03       Impact factor: 44.544

6.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

Authors:  C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

7.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Authors:  Pengyuan Liu; Haris G Vikis; Daolong Wang; Yan Lu; Yian Wang; Ann G Schwartz; Susan M Pinney; Ping Yang; Mariza de Andrade; Gloria M Petersen; Jonathan S Wiest; Pamela R Fain; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Teresa Coons; Juwon Lee; Elena Kupert; Daniela Seminara; John Minna; Joan E Bailey-Wilson; Xifeng Wu; Margaret R Spitz; Timothy Eisen; Richard S Houlston; Christopher I Amos; Marshall W Anderson; Ming You
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

9.  Lung cancer incidence and long-term exposure to air pollution from traffic.

Authors:  Ole Raaschou-Nielsen; Zorana Jovanovic Andersen; Martin Hvidberg; Steen Solvang Jensen; Matthias Ketzel; Mette Sørensen; Steffen Loft; Kim Overvad; Anne Tjønneland
Journal:  Environ Health Perspect       Date:  2011-01-12       Impact factor: 9.031

10.  Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.

Authors:  Hiromasa Yamamoto; Koichiro Higasa; Masakiyo Sakaguchi; Kazuhiko Shien; Junichi Soh; Koichi Ichimura; Masashi Furukawa; Shinsuke Hashida; Kazunori Tsukuda; Nagio Takigawa; Keitaro Matsuo; Katsuyuki Kiura; Shinichiro Miyoshi; Fumihiko Matsuda; Shinichi Toyooka
Journal:  J Natl Cancer Inst       Date:  2013-12-07       Impact factor: 13.506

View more
  18 in total

1.  Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling.

Authors:  Weijuan Yan; Huijie Yu; Wei Li; Fengsheng Li; Sinian Wang; Nan Yu; Qisheng Jiang
Journal:  Oncol Lett       Date:  2018-09-14       Impact factor: 2.967

2.  Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer.

Authors:  Jinyoung Byun; Younghun Han; Yafang Li; Jun Xia; Erping Long; Jiyeon Choi; Xiangjun Xiao; Meng Zhu; Wen Zhou; Ryan Sun; Yohan Bossé; Zhuoyi Song; Ann Schwartz; Christine Lusk; Thorunn Rafnar; Kari Stefansson; Tongwu Zhang; Wei Zhao; Rowland W Pettit; Yanhong Liu; Xihao Li; Hufeng Zhou; Kyle M Walsh; Ivan Gorlov; Olga Gorlova; Dakai Zhu; Susan M Rosenberg; Susan Pinney; Joan E Bailey-Wilson; Diptasri Mandal; Mariza de Andrade; Colette Gaba; James C Willey; Ming You; Marshall Anderson; John K Wiencke; Demetrius Albanes; Stephan Lam; Adonina Tardon; Chu Chen; Gary Goodman; Stig Bojeson; Hermann Brenner; Maria Teresa Landi; Stephen J Chanock; Mattias Johansson; Thomas Muley; Angela Risch; H-Erich Wichmann; Heike Bickeböller; David C Christiani; Gad Rennert; Susanne Arnold; John K Field; Sanjay Shete; Loic Le Marchand; Olle Melander; Hans Brunnstrom; Geoffrey Liu; Angeline S Andrew; Lambertus A Kiemeney; Hongbing Shen; Shanbeh Zienolddiny; Kjell Grankvist; Mikael Johansson; Neil Caporaso; Angela Cox; Yun-Chul Hong; Jian-Min Yuan; Philip Lazarus; Matthew B Schabath; Melinda C Aldrich; Alpa Patel; Qing Lan; Nathaniel Rothman; Fiona Taylor; Linda Kachuri; John S Witte; Lori C Sakoda; Margaret Spitz; Paul Brennan; Xihong Lin; James McKay; Rayjean J Hung; Christopher I Amos
Journal:  Nat Genet       Date:  2022-08-01       Impact factor: 41.307

3.  The Role of Family Health History in Predicting Midlife Chronic Disease Outcomes.

Authors:  Naomi N Duke; Todd M Jensen; Krista M Perreira; V Joseph Hotz; Kathleen Mullan Harris
Journal:  Am J Prev Med       Date:  2021-07-03       Impact factor: 6.604

4.  Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.

Authors:  Kuei-Feng Lin; Hsiu-Fu Wu; Wei-Chun Huang; Pei-Ling Tang; Ming-Ting Wu; Fu-Zong Wu
Journal:  BMC Pulm Med       Date:  2017-09-06       Impact factor: 3.317

5.  Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.

Authors:  Dawei Yang; Xiaofang Yang; Yang Li; Peige Zhao; Rao Fu; Tianying Ren; Ping Hu; Yaping Wu; Hongjun Yang; Na Guo
Journal:  J Transl Med       Date:  2020-06-17       Impact factor: 5.531

6.  Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models.

Authors:  Anais Del Curatolo; Fabiana Conciatori; Ursula Cesta Incani; Chiara Bazzichetto; Italia Falcone; Vincenzo Corbo; Sabrina D'Agosto; Adriana Eramo; Giovanni Sette; Isabella Sperduti; Teresa De Luca; Mirko Marabese; Senji Shirasawa; Ruggero De Maria; Aldo Scarpa; Massimo Broggini; Donatella Del Bufalo; Francesco Cognetti; Michele Milella; Ludovica Ciuffreda
Journal:  J Exp Clin Cancer Res       Date:  2018-07-09

7.  Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital.

Authors:  Wei Cao; Chenghai Yan; Hailong Wang; Tom Tang; Haifeng Wang; Dujuan Liu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

8.  Chinese Expert Consensus Workshop Report: Guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors.

Authors:  Fujun Zhang; Junjie Wang; Jinhe Guo; Yuliang Li; Xuequan Huang; Zhiyu Guan; Guangyan Lei; Juan Wang; Xin Ye; Xiaogang Zhao; Jing Wang; Ruoyu Wang; Bin Liu
Journal:  Thorac Cancer       Date:  2018-12-06       Impact factor: 3.500

9.  Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases.

Authors:  Roman Teo Oliynyk
Journal:  J Pers Med       Date:  2019-07-22

Review 10.  Radon Biomonitoring and microRNA in Lung Cancer.

Authors:  Rakhmet Bersimbaev; Alessandra Pulliero; Olga Bulgakova; Kussainova Asia; Akmara Aripova; Alberto Izzotti
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.